LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_006218.4_c.331_345del_20261117_144323
Framework: ACMG/AMP 2015
Variant classification summary

NM_006218.4:c.331_345del

PIK3CA  · NP_006209.2:p.(Lys111_Arg115del)  · NM_006218.4
GRCh37: chr3:178916942 AAAAGATCCTCAATCG>A  ·  GRCh38: chr3:179199154 AAAAGATCCTCAATCG>A
Gene: PIK3CA Transcript: NM_006218.4
Final call
VUS
All criteria require review: For research and educational purposes only.
Gene
PIK3CA
Transcript
NM_006218.4
Protein
NP_006209.2:p.(Lys111_Arg115del)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PS2 is not assessed because the required proband, parental, and tissue-comparison data are unavailable; PM6, PP1, and BS4 are not applicable under the VCEP specification.
Final determination: Because no criteria were applied, ACMG/AMP 2015 Table 5's rule for cases not meeting a pathogenic or benign threshold results in a Variant of Uncertain Significance.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: the VCEP excludes PVS1 for this gene.
cspec
PS1 N/A Not applicable: PS1 requires a missense variant, and this is an in-frame indel.
generic_acmg_combination_rules cspec
PS2 Not assessed Not assessed: no proband allele fraction, confirmed parental testing, or affected-versus-other-tissue allele-fraction comparison is available for the variant.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PS3 Not assessed Not assessed: no exact-variant functional assay result is available; the only paper reports a different PIK3CA K111delK deletion.
vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:29533785
PS4 Not assessed Not assessed: the variant is absent from gnomAD, but no affected-case phenotype counts or qualifying Table 2A case evidence are available to assign PS4 points.
cspec gnomad_v2 gnomad_v4 PMID:29533785
PM1 Not met Not met: residues 111-115 fall outside all four approved PIK3CA domains, whose nearest listed interval ends at residue 108.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PM2 Not assessed Not assessed: the variant was absent from four gnomAD datasets, but patient ancestry and an ethnically matched cohort were not documented for the VCEP PM2 requirement.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the VCEP states disease-causing variants are heterozygous, so recessive in-trans evidence is outside PM3's use.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PM4 N/A Not applicable: the VCEP explicitly excludes PM4 for these genes, including rare in-frame indels that might cause gain of function.
cspec
PM5 N/A Not applicable: PM5 requires a missense variant, and this is an in-frame indel.
generic_acmg_combination_rules cspec
PM6 N/A Not applicable: the VCEP directs that assumed de novo evidence without confirmed paternity and maternity is addressed through PS2 and not used as PM6.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP1 N/A Not applicable: the VCEP excludes PP1 because these disease-causing variants are germline mosaic, de novo, or mosaic.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP2 N/A Not applicable: PP2 is restricted to missense constraint, whereas c.331_345del is an in-frame deletion rather than a missense variant.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
PP3 N/A Not applicable: the VCEP excludes PP3 because these PIK3CA variants are gain-of-function and traditional pathogenicity predictors assess loss-of-function mechanisms.
vcep_clingen_brainmalform_acmg_specifications_v1_1
PP4 N/A Not applicable: the VCEP accounts for phenotype specificity under PS4 rather than PP4.
cspec
PP5 N/A Not applicable: this VCEP states that PP5 is not for use.
cspec
BA1 Not met Not met: the variant was absent from gnomAD v2.1, v4.1, and non-cancer subsets, so no allele frequency exceeded the >0.0926% BA1 threshold.
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant was absent from gnomAD v2.1, v4.1, and non-cancer subsets, so no allele frequency exceeded the >0.0185% BS1 threshold.
cspec gnomad_v2 gnomad_v4
BS2 Not met Not met: gnomAD reported no variant occurrences, and no family observations were available to reach the VCEP minimum of 3 homozygotes or heterozygotes.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no exact-variant benign functional result is available; the reported K111delK assay tested a different PIK3CA deletion.
vcep_clingen_brainmalform_acmg_specifications_v1_1 PMID:29533785
BS4 N/A Not applicable: the VCEP excludes BS4 for de novo, germline mosaic, or post-zygotic mutations.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BP1 N/A Not applicable: the VCEP excludes BP1 for this gene.
cspec
BP2 Not assessed Not assessed: no documented cis/trans observation with a pathogenic PIK3CA variant is available to satisfy the applicable BP2 phase rule.
cspec vcep_clingen_brainmalform_acmg_specifications_v1_1
BP3 N/A Not applicable: the VCEP states that these genes lack exon regions that are repetitive and without a known function.
cspec
BP4 N/A Not applicable: BP4 covers synonymous, noncanonical intronic, or UTR variants, whereas this is an exon 2 in-frame deletion.
vcep_clingen_brainmalform_acmg_specifications_v1_1 spliceai
BP5 Not assessed Not assessed: no case documents the variant with an alternate molecular basis for disease.
cspec
BP6 N/A Not applicable: this VCEP states that BP6 is not for use.
cspec
BP7 N/A Not applicable: BP7 covers synonymous, noncanonical intronic, or UTR variants, whereas this is an exon 2 in-frame deletion.
vcep_clingen_brainmalform_acmg_specifications_v1_1
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.